---
symbol: "HIMS"
name: "Hims & Hers"
date: 2026-10-10
change_pct: 9.901588091093199
direction: "up"
event_type: "analyst_action"
url: "https://perplo.app/why/HIMS/2026-10-10"
updated_at: 2026-10-10T01:06:23.977Z
---

# Why Hims & Hers (HIMS) rose 9.90% on October 10, 2026

Hims & Hers (HIMS) rose 9.90% on October 10, 2026 — Peptide demand tailwind lifts Hims despite Citi's downside.

## What happened

Hims & Hers rose on a peptide demand tailwind, with the stock jumping about 7% on the news and closing up 10.5% on the day.

## Why it moved

Peptide products are a new growth line, so rising demand lifts the forward revenue outlook and justifies a higher multiple. That re-rating is what drives the move, not a one-time earnings beat.

## Why it matters

Hims sits in the Meme & Retail Squeezes theme, where retail-heavy names with strong narratives tend to trade on sentiment and momentum more than on hard numbers.

## What would break the thesis

Citi's flagged 17% downside is the counterpoint: if peptide growth slows or guidance weakens, the multiple can compress fast.

## Sources

- [HIMS jumps 7% on peptide tailwind — but Citi sees 17% downside from here](https://www.investing.com/news/stock-market-news/hims-jumps-7-on-peptide-tailwind--but-citi-sees-17-downside-from-here-93CH-4941579) — Investing.com

---

Trade HIMS perpetual futures 24/7 onchain: https://perplo.app/asset/HIMS